KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) Interest Expenses (2020 - 2023)

Clover Health Investments' Interest Expenses history spans 4 years, with the latest figure at $7000.0 for Q2 2023.

  • For Q2 2023, Interest Expenses fell 98.21% year-over-year to $7000.0; the TTM value through Mar 2024 reached $7000.0, down 99.25%, while the annual FY2023 figure was $7000.0, 99.47% down from the prior year.
  • Interest Expenses reached $7000.0 in Q2 2023 per CLOV's latest filing, down from $136000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $10.4 million in Q4 2020 to a low of $7000.0 in Q2 2023.
  • Average Interest Expenses over 4 years is $3.1 million, with a median of $404000.0 recorded in 2021.
  • Peak YoY movement for Interest Expenses: changed 0.0% in 2022, then crashed 98.21% in 2023.
  • A 4-year view of Interest Expenses shows it stood at $10.4 million in 2020, then tumbled by 96.14% to $403000.0 in 2021, then plummeted by 66.25% to $136000.0 in 2022, then plummeted by 94.85% to $7000.0 in 2023.
  • Per Business Quant, the three most recent readings for CLOV's Interest Expenses are $7000.0 (Q2 2023), $136000.0 (Q4 2022), and $404000.0 (Q3 2022).